Early diagnosis is critically important in neurological diseases to prevent irreversible neuronal loss. In conditions such as Alzheimer's, Parkinson's disease, Multiple Sclerosis (MS), and Epilepsy, early-detected biomarkers and imaging findings can slow the progression of the disease. Clinical neurological examination, magnetic resonance imaging (MRI), cerebrospinal fluid analysis, and electrophysiological tests are among the most commonly used methods in early diagnosis.
